Investigational malaria vaccine gives strong, lasting protection: Phase 1 trials
Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to…